Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Germany(2,095/week)
    • Poland(1,374/week)
    • France(1,078/week)
    • Spain(732/week)
    • Czechia(423/week)
    • View all (8,956/week)
  • News
    • United States(527/week)
    • Manufacturing(411/week)
    • Energy(279/week)
    • Technology(410/week)
    • Other Manufacturing(363/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

Blueprint Medicines Corporation

Feb 17, 2021
Blueprint Medicines Reports Fourth Quarter and Full Year 2020 Financial Results
Feb 10, 2021
Blueprint Medicines to Report Fourth Quarter and Full Year 2020 Financial Results on Wednesday, February 17, 2021
Feb 05, 2021
Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Jan 11, 2021
Blueprint Medicines Announces R&D Leadership Transitions
Jan 11, 2021
Blueprint Medicines Reports Portfolio Milestones and Outlines 2021 Roadmap for Precision Medicine Leadership
Jan 05, 2021
Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Dec 17, 2020
Blueprint Medicines Submits Supplemental New Drug Application to FDA for AYVAKIT(TM) (avapritinib) for the Treatment of Advanced Systemic Mastocytosis
Dec 07, 2020
Blueprint Medicines Data Presented at 62nd ASH Annual Meeting and Exposition Highlight Broad Commitment to Advance Patient Care in Systemic Mastocytosis
Dec 01, 2020
Blueprint Medicines Announces FDA Approval of GAVRETO(TM) (pralsetinib) for the Treatment of Patients with Advanced or Metastatic RET-Mutant and RET Fusion-Positive Thyroid Cancer
Nov 23, 2020
Blueprint Medicines To Present Broad Range of Data Reinforcing Commitment to Advance Patient Care in Systemic Mastocytosis at 62nd ASH Annual Meeting and Exposition
Oct 29, 2020
Blueprint Medicines Reports Third Quarter 2020 Financial Results
Oct 22, 2020
Blueprint Medicines to Report Third Quarter 2020 Financial Results on Thursday, October 29, 2020
Sep 17, 2020
Blueprint Medicines Presents Foundational Preclinical Data for BLU-945 Showing Robust Anti-Tumor Activity in Treatment-Resistant EGFR-Mutated Lung Cancer at ESMO Virtual Congress 2020
Sep 09, 2020
Blueprint Medicines to Present at 18th Annual Morgan Stanley Global Healthcare Conference
Sep 01, 2020
Blueprint Medicines Strengthens Leadership with Appointment of Fouad Namouni, M.D., as President, Research & Development
Aug 04, 2020
Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Jul 30, 2020
Blueprint Medicines Reports Second Quarter 2020 Financial Results
Jul 23, 2020
Blueprint Medicines to Report Second Quarter 2020 Financial Results on Thursday, July 30, 2020
Jul 14, 2020
Blueprint Medicines Announces Global Collaboration with Roche to Develop and Commercialize Pralsetinib for Patients with RET-Altered Cancers
Jul 02, 2020
Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
  •  
  • Page 1
  • ››

Latest News

Aug 13, 2022

Dubai Electricity and Water Authority PJSC announces AED 12.08 billion revenue and 3.30 billion net profit in...

Aug 13, 2022

Statement from Silfab Solar on Passage of Inflation Reduction Act

Aug 13, 2022

Westlake Announces $500 Million Expansion of Existing Share Repurchase Program and 20% Increase in Quarterly...

Aug 13, 2022

CHFC Celebrates the Creation of a Hydrogen Production Tax Credit in the IRA

Aug 13, 2022

CURC Celebrates the Enhancements to 45Q in the IRA

Aug 13, 2022

ArborWorks LLC Announces the Promotion of Mr. Clint Stephens to Vice President of Operations, Southeastern...

Aug 13, 2022

Calvert Impact Capital releases statement on Inflation Reduction Act

Aug 13, 2022

Tigray rebels deny 'direct engagements' with Ethiopia govt

View all News

Agenda

17
November
The NetherlandsAhoy, Rotterdam
NIDV Exhibition Defence and Security, November 17, 2022, Ahoy Rotterdam
The NIDV Exhibition Defence and Security (NEDS) is the annual event for the Defence and Security industry and...
02
November
GreeceAthens
mastMED 2022 - Maritime/Air Systems & Technologies, 2-4 November, Athens, Greece
“The Mediterranean: Laboratory for Naval Warfare” Between 2–4 November 2022, Athens will be the first Greek city to...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
© 2022 EPICOS
Made by Wedia